India, June 25 -- Danish pharmaceutical company Novo Nordisk launched its weight-loss drug Wegovy in India, which has the third highest obese population in the world, the company announced on Tuesday. The much-awaited drug can be self-administered at home, the company added. Wegovy, the company said, will be available in a once-a-week innovative pen device in five dose strengths - 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and a maintenance dosing of 2.4 mg. The price for 0.25, 0.5, and 1 mg doses is Rs.17,345 a month, and for 1.7 and 2.4 mg, Rs.24,280 and Rs.26,050 a month, respectively.P12...